Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2023-07-18
2025-02-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective of the study: In the present study the effectiveness of short-term SFGT (protocol of De Jager, Burger \& Groot) on (1) persistent anxiety and depressive symptoms, and (2) early maladaptive schemas (EMS), experiential avoidance and the mode of the healthy adult will be investigated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Schema Therapy for Treatment-resistant Anxiety Disorders
NCT06298695
Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders
NCT00247234
Adjunct Interpersonally Focused Psychodynamic Group Psychotherapy for Residual Depression Symptoms
NCT02449499
Strengthening the Healthy Adult Mode: a Case Experimental Study Exploring the Effects of a New Schema Therapy Protocol in an Adult Outpatient Population.
NCT04466163
The Influence of Treatment Format on Schema Therapy for Borderline Personality Disorder
NCT05986552
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SFGT
Whitin subject design with one arm; SFGT groep intervention
short-term schema focused group therapy
There are two intervention phases. The first concerns the pre-treatment phase, which consists of five online sessions and three face-to-face sessions. The second intervention phase is the short-term SFGT. The SFGT consists of 17 weekly group sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
short-term schema focused group therapy
There are two intervention phases. The first concerns the pre-treatment phase, which consists of five online sessions and three face-to-face sessions. The second intervention phase is the short-term SFGT. The SFGT consists of 17 weekly group sessions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of at least one previous evidence-based therapy focused on anxiety, depression or PTSD according to the Dutch national guidelines.
* Able to comprehend Dutch at a level sufficient to complete self-report.
Exclusion Criteria
* Start of (or change in) medication which is not yet stabilized at the start of this study.
* Psychosocial problems such as homelessness, no income or high debts which would make the clients unable to participate in a group.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GGZ Noord-Holland-Noord
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eva Velthorst, PhD
Role: PRINCIPAL_INVESTIGATOR
GGZ Noord-Holland-Noord
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stichting GGZ Noord-Holland-Noord
Heerhugowaard, North Holland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL83423.018.22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.